Target intelligence / Profile preview

Neuroimmune modulation

Molecular classification
Other (physiological process), Receptor, G protein-coupled receptors, Ion channel, Enzyme
01

Overview

Neuroimmune modulation refers to the bidirectional communication between the nervous system and immune system that regulates inflammatory responses throughout the body. This interaction occurs through defined anatomical structures known as neuro–immune cell units where neurons and immune cells colocalize. Key mechanisms include neurotransmitter release from nerves affecting local immunity, expression of neurotransmitter receptors on immune cells enabling direct neuronal control over cytokine production, and feedback loops involving central autonomic circuits like those mediated by the vagus nerve ("cholinergic anti-inflammatory pathway") which can dampen excessive inflammation without broadly suppressing immunity. Therapeutically targeting these pathways—most notably using electrical vagus nerve stimulation—is being explored for treatment-refractory autoimmune/inflammatory conditions such as Crohn’s disease, rheumatoid arthritis, and potentially multiple sclerosis due to its ability to reduce pro-inflammatory cytokines while preserving host defense functions.[1][3][4][6][8][9] “Neuroimmune modulation involves tapping into neural reflex arcs that allow the brain to communicate with the immune system... The vagus nerve... acts as an immune sentry... resetting how robust the immune reaction should be.” [9] In summary: • "Neuroimmune modulation" is not a discrete molecular target. • It encompasses complex physiological processes involving many molecules/receptors. • The most clinically advanced application is device-based vagus nerve stimulation.

Other names
NeuroimmunomodulationNeuroimmune regulationCholinergic anti-inflammatory pathwayInflammatory reflex
02

Mechanism of action

Electrical stimulation of vagus nerve activates afferent/efferent neural circuits that suppress pro-inflammatory cytokine release via α7 nicotinic acetylcholine receptors on immune cells—reducing NFκB activation and inflammasome activity without global immunosuppression. Catecholamines released from nerves can suppress lymphocyte activation through cAMP-dependent/independent signaling in T/B cells. Activation of specialized brainstem centers via neural reflex arcs resets peripheral inflammatory setpoints ("inflammatory reflex").

03

Biological functions

Immune response regulationSignal transductionModulation of inflammationMaintenance of homeostasis/allostasisNeuroprotection/remyelination in CNS diseases
04

Disease associations

Inflammatory diseases: Modulates chronic inflammation; e.g., Crohn’s diseaseAutoimmune diseases: Regulates aberrant immune activation; e.g., rheumatoid arthritisNeurodegenerative diseases: May reduce neuroinflammation/promote remyelination; e.g., MSGastrointestinal disorders: Controls gut inflammation via enteric nervous system
05

Safety considerations

Device-related risks with implanted stimulators (infection at implant site)Potential off-target autonomic effects depending on stimulation parametersGenerally considered safe with low risk of systemic immunosuppression compared to biologics
06

Interacting drugs

Vagus nerve stimulation devices for Crohn’s disease and rheumatoid arthritis

2 more in the full profile.

07

Biomarkers

Serum TNFα levelsFaecal calprotectin (for gut inflammation/Crohn's disease)Clinical indices such as CDAI in Crohn's disease trialsNo universal biomarker—depends on indication

Beyond the preview

Go deeper on Neuroimmune modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroimmune modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call